The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Post-transplant lymphoproliferative disorder in kidney transplant patients: A multicenter report.
 
Elise A. Chong
Consulting or Advisory Role - Bristol-Myers Squibb; Kite, a Gilead company; Novartis; Tessa Therapeutics
 
Daniel E. Tsai
No Relationships to Disclose
 
Mitchell E. Hughes
Consulting or Advisory Role - Abbvie; AstraZeneca; AstraZeneca; Genzyme; Janssen Oncology; Karyopharm Therapeutics
Research Funding - HOPA/Acerta Pharma
 
Mary Ann C Lim
No Relationships to Disclose
 
Behdad D. Besharatian
No Relationships to Disclose
 
Yvonne El Kassiss
No Relationships to Disclose
 
Roy Bloom
Stock and Other Ownership Interests - Gilead Sciences
Honoraria - AlloVir; CareDX; Natera; Paladin; Veloxis
Consulting or Advisory Role - Veloxis
Research Funding - CareDX; CSL Behring; Natera; Veloxis
Patents, Royalties, Other Intellectual Property - UpToDate
 
Deepa Jagadeesh
Consulting or Advisory Role - Atara Biotherapeutics; Kyowa Hakko Kirin; Verastem
Speakers' Bureau - Verastem
Research Funding - ADC Therapeutics (Inst); AstraZeneca (Inst); Debiopharm Group (Inst); MEI Pharma (Inst); MEI Pharma (Inst); Regeneron (Inst); Rhizen Pharmaceuticals (Inst); Seagen (Inst); Seagen (Inst); Seagen (Inst); Seagen (Inst); Trillium Therapeutics (Inst)